- Arclin will buy DuPont’s Aramids business (Kevlar® and Nomex®) for about $1.8B, adding roughly 1,900 employees, with closing targeted for Q1 2026.
- CompoSecure and Husky will merge at a pro forma ~$7.4B enterprise value, funded with a $2B PIPE and $1B equity rollover, targeting 20%+ EPS accretion.
- CD&R agreed to acquire Sealed Air for ~$10.3B EV, paying $42.15 per share in cash, with closing expected mid-2026.
- The deals signal strong plastics and packaging M&A momentum but carry execution risks around approvals, leverage, and post-merger integration amid uncertain macro conditions.
Read More
The plastics and materials sector is witnessing a wave of large-scale M&A activity in late 2025 through early 2026, driven in part by firms seeking portfolio expansion, higher margins, and strategic positioning. The deals by Arclin, CompoSecure/Husky, and CD&R/Sealed Air highlight several emerging trends and strategic inflection points.
Strategic repositioning through acquisition of materials and IP assets. Arclin’s acquisition of the Kevlar® and Nomex® brands from DuPont for approximately $1.8 billion is not just a scale deal; it provides Arclin access to high-growth end markets (like protective gear, EV infrastructure, defense) and widely recognized premium IP. Such a move enhances its materials platform and accelerates its innovation strategy.
Building diversified industrial platforms. CompoSecure’s merger with Husky (valued at ~$7.4 billion EV) combines CompoSecure’s payment metal card technology and security solutions with Husky’s injection-molding equipment business. This vertical and horizontal integration expands capabilities, adds recurring revenue from aftermarket services, and allows operating leverage, with forecasts of 20%+ EPS accretion post-close.
Premium valuations driven by end market strength and operational clarity. Sealed Air’s sale at a 41% premium for shareholders and a total EV of ~US$10.3B reflects packaging markets’ strength, especially in food-service and protective products. Multiple disclosures around valuation, cash flows, and leverage in the CompoSecure deal also underscore tighter scrutiny from investors.
Financial risk factors and integration challenges. Among the key risks: debt loads post-transaction (e.g., net debt of ~$1.7B estimated for CompoSecure/Husky), regulatory and antitrust approvals, maintaining synergy realization, cultural integrations, and global supply chain stability. The timing of closings—many in Q1-mid 2026—means macroeconomic headwinds like interest rates, inflation, and trade policy could still impact outcomes.
Open questions and what to watch in 2026. Will new regulatory scrutiny on chemicals and protective materials affect Arclin? Can CompoSecure sustain both organic growth and integration of large machinery business? Will Sealed Air retain performance under new ownership? Lastly, whether valuations remain elevated in weaker end markets (e.g., automotive or consumer durables) will test resilience.
Supporting Notes
- Arclin’s deal to acquire DuPont’s Aramids business, including Kevlar® and Nomex®, is priced at ~$1.8 billion.
- The acquisition involves about 1,900 employees and is expected to close in Q1 2026, subject to usual regulatory approvals. [0search0][0search1]
- CompoSecure and Husky’s combination is valued at ~$7.4 billion enterprise value, with Husky’s part being approximately $5 billion on an implied EBITDA multiple of ~11.2×. [0search3][0search7]
- The CompoSecure/Husky deal financing comprises a $2 billion PIPE and $1 billion equity rollover, improving ownership continuity and financial structuring. [0search3][0search10]
- Sealed Air agreed to a $10.3 billion acquisition by CD&R, paying shareholders $42.15 per share, reflecting a ~41 % premium, with closing expected mid-2026. [0search6][0news13]
- In CompoSecure’s Q3 2025: net sales rose 13% year-over-year to $120.9 million; gross margin improved to 59%; adjusted EBITDA increased roughly 30%. [0search8][0search5]
- DuPont will receive $1.2 billion cash, $300 million note, and keep a ~17.5 % equity stake (~US$325 million value) in the post-Arclin entity. [0search1]